Inquire About a Product| Product: | Vincristine-d3 Sulfate | ||||
|---|---|---|---|---|---|
| Catalog Number: | D31951 | ||||
| CAS Number: | 1217854-24-4 | ||||
| Synonyms: |
22-Oxovincaleukoblastine-d3 Sulfate; Leurocristine-d3 Sulfate; Kyocristine-d3; Lilly 37231-d3; NSC 67574-d3; Novopharm-d3; Oncovin-d3; Onkovin-d3; VCR Sulfate-d3; Vincasar PFS-d3; Vincrisul-d3 |
||||
| Pricing: |
|
||||
| Formula: | C46H55D3N4O14S | ||||
| Molecular Weight: | 926.05 | ||||
| Structure: |
|
||||
| Category: | Heterocyclic Compounds | ||||
| Literature References: |
Graf, W. D.; Chance, P. F.; Lensch, M. W.; Eng, L. J.; Lipe, H. P.; Bird, T. D., Severe Vincristine Neuropathy in Charcot-Marie-Tooth Disease Type 1A. Cancer, 1996, 77 (7): 1356–1362.; Hiddemann, W., et al., Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood, 2005, Dec., 106(12):3725-3732. |
||||
| MSDS: | |||||
| Applications: | A labeled chemotherapy medication. Used to treat multiple types of cancers. Inhibits mitosis causing cells death. Binds to tubulin protein, prohibiting chromosome separation during metaphase. Mainly used for non-Hodgkin's lymphoma. |